Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Cogle

Showing results (91-100 of 137) with videos related to

Pageof 14
Sort By:
Leukemia & Lymphoma|September 15, 2015
Clinical significance of in vivo cytarabine-induced gene expression signature in AMLJatinder K Lamba, Stanley Pounds, Xueyuan Cao, et al.
Cytotherapy|February 10, 2016
Ex vivo virotherapy with myxoma virus does not impair hematopoietic stem and progenitor cellsNancy Y Villa, Swarna Bais, Winnie M Chan, et al.
Clinical Transplantation|May 25, 2016
Effect of melphalan 140 mg/m(2) vs 200 mg/m(2) on toxicities and outcomes in multiple myeloma patients undergoing single autologous stem cell transplantation-a single center experienceLakshmikanth Katragadda, Lindsay M McCullough, Yunfeng Dai, et al.
JAMA Oncology|May 15, 2020
Clinical Application of Computational Methods in Precision Oncology: A ReviewOrestis A Panagiotou, Lori Hoffman Högg, Hedvig Hricak, et al.
Leukemia Research|May 2, 2016
A new model to predict remission status in AML patients based on day 14 bone marrow biopsyMaxim Norkin, Myron Chang, Qi An, et al.
Transfusion|April 24, 2015
Vitamin D effect on umbilical cord blood characteristics: a comparison between African Americans and CaucasiansLamis K Eldjerou, Christopher R Cogle, Emma H Rosenau, et al.
Blood|September 1, 2009
Bone marrow stem and progenitor cell contribution to neovasculogenesis is dependent on model system with SDF-1 as a permissive triggerGerard J Madlambayan, Jason M Butler, Koji Hosaka, et al.
Leukemia Research|November 18, 2016
Computational drug treatment simulations on projections of dysregulated protein networks derived from the myelodysplastic mutanome match clinical response in patientsLeylah Drusbosky, Cindy Medina, Regina Martuscello, et al.
Blood|April 10, 2013
PARP1 is required for chromosomal translocationsJustin Wray, Elizabeth A Williamson, Sudha B Singh, et al.
Blood Cancer Journal|November 28, 2017
Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemiaMaxim Norkin, Lakshmikanth Katragadda, Fei Zou, et al.
Pageof 14

Showing results (91-100 of 137) with videos related to

Sort By:
Pageof 14
Leukemia & Lymphoma|September 15, 2015
Clinical significance of in vivo cytarabine-induced gene expression signature in AMLJatinder K Lamba, Stanley Pounds, Xueyuan Cao, et al.
Cytotherapy|February 10, 2016
Ex vivo virotherapy with myxoma virus does not impair hematopoietic stem and progenitor cellsNancy Y Villa, Swarna Bais, Winnie M Chan, et al.
Clinical Transplantation|May 25, 2016
Effect of melphalan 140 mg/m(2) vs 200 mg/m(2) on toxicities and outcomes in multiple myeloma patients undergoing single autologous stem cell transplantation-a single center experienceLakshmikanth Katragadda, Lindsay M McCullough, Yunfeng Dai, et al.
JAMA Oncology|May 15, 2020
Clinical Application of Computational Methods in Precision Oncology: A ReviewOrestis A Panagiotou, Lori Hoffman Högg, Hedvig Hricak, et al.
Leukemia Research|May 2, 2016
A new model to predict remission status in AML patients based on day 14 bone marrow biopsyMaxim Norkin, Myron Chang, Qi An, et al.
Transfusion|April 24, 2015
Vitamin D effect on umbilical cord blood characteristics: a comparison between African Americans and CaucasiansLamis K Eldjerou, Christopher R Cogle, Emma H Rosenau, et al.
Blood|September 1, 2009
Bone marrow stem and progenitor cell contribution to neovasculogenesis is dependent on model system with SDF-1 as a permissive triggerGerard J Madlambayan, Jason M Butler, Koji Hosaka, et al.
Leukemia Research|November 18, 2016
Computational drug treatment simulations on projections of dysregulated protein networks derived from the myelodysplastic mutanome match clinical response in patientsLeylah Drusbosky, Cindy Medina, Regina Martuscello, et al.
Blood|April 10, 2013
PARP1 is required for chromosomal translocationsJustin Wray, Elizabeth A Williamson, Sudha B Singh, et al.
Blood Cancer Journal|November 28, 2017
Minimal residual disease by either flow cytometry or cytogenetics prior to an allogeneic hematopoietic stem cell transplant is associated with poor outcome in acute myeloid leukemiaMaxim Norkin, Lakshmikanth Katragadda, Fei Zou, et al.
Pageof 14